Clinical Trials Directory

Trials / Completed

CompletedNCT02480322

Metabolomic Fingerprint After Bariatric Surgery

Metabolomic Fingerprint of Severe Obesity is Dynamically Affected by Bariatric Surgery in a Procedure-dependent Manner

Status
Completed
Phase
Study type
Observational
Enrollment
106 (actual)
Sponsor
eSwiss Medical & Surgical Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Background: Obesity is associated with multiple diseases. Bariatric surgery is the most effective therapy for severe obesity that cannot only reduce body weight but also obesity-associated morbidity. Objective: The metabolic alterations associated with obesity and respective changes after bariatric surgery are incompletely understood. Design: In the longitudinal observational study, the investigator applied a 1H-NMR-based global, untargeted metabolomics strategy on human serum samples that were collected before and repeatedly up to one year after distinct bariatric procedures (sleeve gastrectomy, proximal and distal Roux-en Y gastric bypass; RYGB). For comparison, the investigator also analyzed serum samples from normal-weight and less obesity obese subjects that were matched for 1-year postoperative BMI values of the surgical groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREbariatric surgery (sleeve resection, proximal RYGB, distal RYGB)

Timeline

Start date
2010-05-01
Primary completion
2012-05-01
First posted
2015-06-24
Last updated
2015-06-25

Source: ClinicalTrials.gov record NCT02480322. Inclusion in this directory is not an endorsement.

Metabolomic Fingerprint After Bariatric Surgery (NCT02480322) · Clinical Trials Directory